Condition: Prostate Cancer · Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
This study addresses the global topic of treatment optimization, i.e. achieving similar benefit while reducing the duration of treatment, hence hoping to decrease the burden of side-effects, improve quality-of life and reduce resource utilization. The primary goal of de-escalation is to investigate whether using an intermittent regime results in a similar OS to continuous treatment.
This description comes directly from the study's public registry record.
EORTC · +3227741611 · eortc@eortc.org
Always discuss trial participation with your own doctor first.
| University Hospitals Copenhagen - Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Centre Francois Baclesse | Caen, France | Recruiting |
| Institut Daniel Hollard | Grenoble, France | Recruiting |
| Clinique La Croix Du Sud | Quint-Fonsegrives, France | Recruiting |
| CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole | Toulouse, France | Recruiting |
| Gustave Roussy | Villejuif, France | Recruiting |
| Hospital De La Santa Creu I Sant Pau | Barcelona, Spain | Recruiting |
| Hospital Universitario San Carlos | Madrid, Spain | Recruiting |
| Hospital Universitario Puerta De Hierro | Majadahonda, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05974774